Charles River Laboratories International, Inc. (CRL)
NYSE · Healthcare
Charles River Laboratories International, Inc. Operating Income 2008–2025
Charles River Laboratories International, Inc. annual/quarterly operating income history and growth rate from 2008 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Charles River Laboratories International, Inc. operating income for the quarter ending March 28, 2026 was 119.9 M, a 60.57% increase year-over-year.
- Charles River Laboratories International, Inc. operating income for the twelve months ending March 28, 2026 was 428.5 M, a 21.60% decrease year-over-year.
- Charles River Laboratories International, Inc. annual operating income for 2025 was 25.2 M, a 88.93% decrease from 2024.
- Charles River Laboratories International, Inc. annual operating income for 2024 was 227.3 M, a 63.17% decrease from 2023.
- Charles River Laboratories International, Inc. annual operating income for 2023 was 617.3 M, a 5.18% decrease from 2022.
- Charles River Laboratories International, Inc. annual operating income for 2022 was 651.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Charles River Laboratories International, Inc. Operating Income — FAQ
Charles River Laboratories International, Inc. (CRL) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Charles River Laboratories International, Inc.'s operating income?
Charles River Laboratories International, Inc. (CRL) reported operating income of $25M for fiscal 2025.
Where can I see CRL's operating income history?
The chart and table above show Charles River Laboratories International, Inc.'s operating income by year and by quarter, including the growth rate.